ARK Genomic Revolution ETF
ARKG
ARKG
285 hedge funds and large institutions have $433M invested in ARK Genomic Revolution ETF in 2023 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 63 increasing their positions, 88 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
less first-time investments, than exits
New positions opened: | Existing positions closed:
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less ownership
Funds ownership: →
28% less repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 88
35% less capital invested
Capital invested by funds: $666M → $433M (-$233M)
Holders
285
Holding in Top 10
3
Calls
$36.9M
Puts
$40.3M
Top Buyers
| 1 | +$5.57M | |
| 2 | +$3.8M | |
| 3 | +$3.53M | |
| 4 |
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
|
+$2.02M |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.01M |
Top Sellers
| 1 | -$41.2M | |
| 2 | -$32.2M | |
| 3 | -$23M | |
| 4 |
Citigroup
New York
|
-$21.5M |
| 5 |
Morgan Stanley
New York
|
-$4.72M |